Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03669575 · ClinicalTrials.gov registry record · NA

Omega 7 Oil and Inflammatory Biomarker Study

A NA study of Musculoskeletal Pain, sponsored by Bastyr University.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT03669575 is a NA study of Musculoskeletal Pain that has completed, run by Bastyr University. The registered enrollment target is 56 participants, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03669575, a NA study of Musculoskeletal Pain, has completed, sponsored by Bastyr University.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of a single crossover is divided into 1:1 and each supplementation is three weeks with no washout in between.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT omega 7

Study Locations (1)

Washington

  • Bastyr University Clinical Research Center - Kenmore

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2017-09-01
Est. Completion 2019-10-01
Phase NA

Sponsor

Bastyr University

19 total trials

What the Registry Record Tells You About NCT03669575

The ClinicalTrials.gov registry entry for NCT03669575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (64% lower). The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03669575 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT03669575 about?

NCT03669575 is a clinical study titled "Omega 7 Oil and Inflammatory Biomarker Study". The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of...

What is the current status of trial NCT03669575?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2017-09-01. Estimated completion is 2019-10-01.

What conditions does trial NCT03669575 study?

This clinical trial studies the following conditions: Musculoskeletal Pain.

What interventions are being tested in trial NCT03669575?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), omega 7 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03669575?

This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03669575 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.